Pancreatic Cancer Research

ResearcherGuangdong Academy of Medical SciencesNo recent work listed

Sheng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-8610-6015; OpenAlex author ID A5100320975. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

  1. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. Co-author DOI 10.1111/jcmm.15125↗
  2. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway. Last author DOI 10.1186/s13046-019-1313-x↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Zhou · 2 shared papers, 2019–2020 · strength 0.22
  2. Zi Yin · 2 shared papers, 2019–2020 · strength 0.22
  3. Yiping Zou · 2 shared papers, 2019–2020 · strength 0.22
  4. Ning Shi · 1 shared paper, 2020 · strength 0.12
  5. Chuanzhao Zhang · 1 shared paper, 2020 · strength 0.12
  6. Baohua Hou · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.